Over the past year, XRAYS has become a reliable resource for improving our readers’ understanding of breast cancer related news. Since launching on August 25, 2015, XRAYS has made sense of what can often be confusing cancer headlines; empowering cancer survivors, people at high risk for breast cancer, and their families to make better decisions for their health and their well-being.
The XRAYS team consists of medical experts that go behind the headlines, separating help from hype, as they review and explain the research and media articles related to breast cancer research. The XRAYS program is a CDC-funded initiative of Facing Our Risk of Cancer Empowered (FORCE), which is the only organization that’s dedicated to families facing hereditary breast, ovarian, and related cancers.
Not only are we dedicated to bringing you the most up to date information regarding new media articles and research studies, but we’re also focused on sharing information that is relevant to you. As a testament to our purpose, XRAYS strives to bring relevant and timely content on subjects that appeal to our readers.
With over 32,000 views on XRAYS’ reviews alone, we’re dedicated to impacting the way that those affected by cancer or at high risk for cancer are treating their prognosis, whether it’s understanding more about alternative treatments, genetic testing, risk management, or survivorship. (View our full topic list here.)
In just one of our most read topics, genetic testing, our experts reviewed fifteen different studies and the corresponding media articles, giving our readers an informative outlook on topics such as BRCA gene testing including a study on racial disparities in BRCA testing. The study found that black women receive BRCA testing less frequently than white women, despite having a similar, if not higher risk than non-Jewish white women of carrying a BRCA mutation.
Another XRAYS review examined the increase of BRCA testing in young women with breast cancer, finding that 30% of women who were tested felt it made a difference in future treatment options. And another review examined the cost-effectiveness of universal BRCA screenings. As the cost of BRCA testing decreases, many medical experts have argued to consider the possibility of universal testing as an overall benefit gained in terms of cancers found and lives improved.
These reviews are just an example of how XRAYS covers a broad range of topics in detail from various angles to offer the most in-depth information available. Our site is dedicated to helping those affected by cancer make better decisions regarding treatment and management.
As we begin our second year, we are looking for our readers to share what topics are relevant to them and to offer suggestions on how we can improve our site to reflect what you need to know when it comes to making sense of cancer headlines. If there’s a topic that you want to see more of, or a topic that we currently don’t cover, please contact us at firstname.lastname@example.org.